Cohen Medical Associates is a family medical center and research center located in Delray Beach, FL.
Fax: 561-496-7989

Recent Posts

Title Image


Home  /   Blog

When a loved one goes into the hospital, the last thing you’d expect is that they would suddenly turn into someone else overnight. But that’s what can happen with a little-known phenomenon called “hospital-acquired delirium.” Because it occurs frequently, our primary care doctors in Delray Beach want to let you know what it is, and what you can do about it. Sudden Onset Writing in the New York Times, author and producer Susan Seliger detailed how her “lucid and whip-smart” 85-year-old mother fell and broke her hip. She survived the surgery with no problem. “But within 24 hours, a totally different woman seemed to

Our primary care doctors in Delray Beach told you a few weeks ago how important hydration is to maintaining your health. It’s especially valuable for seniors because adults over the age of 60 are at higher risk of dehydration; thirst levels tend to drop with age, especially in winter. Now a new National Institutes of Health (NIH) study published this month in the journal eBioMedicine suggests that drinking enough water is associated with: significantly lower risk of developing chronic diseases lower risk of being biologically older than your chronological age and a lower risk of dying early “The results suggest that proper hydration

This month, the World Health Organization (WHO) warned that the newest COVID-19 variant, known as XBB.1.5, is the most transmissible subvariant we’ve seen so far. Mehul Suthar, who studies emerging viral infections at the Emory University School of Medicine in Atlanta, told USA Today that XBB.1.5 appears to be about five times more contagious than earlier omicron variants, which were five times more contagious than the original virus. What We Know About XBB.1.5 Here are a few facts your primary care doctors in Delray Beach think you should know about the latest COVID-19 variant. It is the first recombinant variant of the COVID-19

Stroke is a leading cause of death in the U.S., and is a major cause of serious disability for adults, according to the Centers for Disease Control and Prevention (CDC). Currently, more than 20 percent of Americans take cholesterol-lowering drugs known as statins to lower their risk of a first heart attack or stroke due to a blood clot. So our primary care doctors in Delray Beach were pleased to hear of a new study showing that statins may also help decrease the risk of a first stroke as a result of an intracerebral hemorrhage, the most deadly type of stroke. Published

The start of a new year is traditionally the time we vow to do better in various areas of our lives because it’s bright with the promise of new beginnings. But over the years, we tend to become disenchanted with the idea of trying to change, because of the trail of resolutions that weren’t kept. If that describes you, our primary care doctors in Delray Beach want to suggest a few simple resolutions you can make to improve your health and your life that are easy to keep. Prioritize Sleep This may be the most important change you can make in your life if

If you regularly enjoy ultra-processed foods like hot dogs, cakes, and white bread, a new study warns that you may be increasing your risk for dementia. Dementia affects nearly 6.5 million Americans, and the Centers for Disease Control and Prevention (CDC) predicts that by 2060, that number could rise as high as 14 million of us. Our primary care doctors in Delray Beach understand the attraction of these foods: They’re deliberately designed to appeal to our taste buds, in addition to being super-convenient. But ultra-processed foods—meaning those that are as far away from their natural state as possible—have been linked to various

If you’re one of the 32 million Americans who suffer from osteoarthritis of the knee, our primary care doctors in Delray Beach want to alert you to a new study that may impact how you’re treated for that condition. Osteoarthritis of the knee will affect at least half of people in their lifetime and accounts for the majority of the more than 700,000 knee replacements in the U.S. each year. What is Arthritis? Arthritis is an informal way of referring to more than 100 types of joint disease, but the two most common forms are osteoarthritis and rheumatoid arthritis. The typical symptoms associated with

If you are an older American or love someone who is, our primary care doctors in Delray Beach saw a recent statistic that should give you pause: Nearly nine out of ten deaths from COVID-19 are now in people 65 or older. While many people believe—and are behaving as though—the pandemic is over, the 300-plus daily deaths still being reported by the Centers for Disease Control and Prevention (CDC) prove it is not. And the most recent figures show that seniors are paying the highest price for that common misconception. According to an analysis by The Washington Post, in October people 85

You may think that because nearly all the media attention regarding the respiratory illness RSV has been focused on children you don’t have to worry. But our primary care doctors in Delray Beach want you to know that it can and does kill adults, too, especially if they’re older or immunocompromised. It’s important to know this, because this year the virus is spreading at “unprecedented” levels, according to many doctors, and it began in the summer, instead of December and January, the usual RSV season. “I’ve been at Connecticut Children’s [Hospital] for 25 years, and I’ve never seen this level of surge specifically

Our primary care doctors in Delray Beach regret to report that for the second time in under two years, a promising drug treatment for Alzheimer’s disease has come up short. Genentech, a division of drug maker Roche, reported this month that the treatment they’d hoped would slow the progression of Alzheimer’s—called gantenerumab—did not meet their goal of slowing clinical decline in people with early Alzheimer’s disease. But other studies provide hope. The Trials Genentech conducted two global, placebo-controlled clinical trials on nearly 2,000 patients over 27 months. Half the subjects received a placebo and half received the treatment, a monoclonal antibody. Gantenerumab is designed to